Hypoxia in prostate cancer: observation to intervention.
Lawrence
Yaacov Richard
YR
Dicker
Adam P
AP
D000818:Animals; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001918:Brachytherapy / Q000379:methods; D015687:Cell Hypoxia; D004195:Disease Models, Animal; D006801:Humans; D006931:Hyperbaric Oxygenation / Q000379:methods; D051793:Hypoxia-Inducible Factor 1 / Q000235:genetics / Q000378:metabolism*; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000235:genetics / Q000378:metabolism*; D008297:Male; D010101:Oxygen Consumption / Q000502:physiology; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000378:metabolism* / Q000401:mortality / Q000628:therapy; D018714:Radiotherapy, Adjuvant; D051381:Rats; D012680:Sensitivity and Specificity; D016019:Survival Analysis; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; C497442:HIF1A protein, human; D051793:Hypoxia-Inducible Factor 1; D051795:Hypoxia-Inducible Factor 1, alpha Subunit